Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Invasive Versus Medical Management in Patients With Prior Coronary Artery Bypass Surgery With a Non-ST Segment Elevation Acute Coronary Syndrome.

Lee MMY, Petrie MC, Rocchiccioli P, Simpson J, Jackson CE, Corcoran DS, Mangion K, Brown A, Cialdella P, Sidik NP, McEntegart MB, Shaukat A, Rae AP, Hood SHM, Peat EE, Findlay IN, Murphy CL, Cormack AJ, Bukov NB, Balachandran KP, Oldroyd KG, Ford I, Wu O, McConnachie A, Barry SJE, Berry C; CABG-ACS Investigators.

Circ Cardiovasc Interv. 2019 Aug;12(8):e007830. doi: 10.1161/CIRCINTERVENTIONS.119.007830. Epub 2019 Jul 31.

PMID:
31362541
2.

Diagnostic utility of cardiac magnetic resonance imaging in STEMI survivors after emergency PCI.

McGeoch RJ, Payne AR, Woodward R, Saul A, Steedman T, Foster J, Hood S, Peat E, Lindsay MM, Petrie MC, Rae AP, McEntegart M, Eteiba H, Tzemos N, Oldroyd KG, Berry C.

Int J Cardiol. 2013 Oct 3;168(3):2933-4. doi: 10.1016/j.ijcard.2013.03.179. Epub 2013 May 20. No abstract available.

PMID:
23701926
3.

Role of multidetector computed tomography in the diagnosis and management of patients attending the rapid access chest pain clinic, The Scottish computed tomography of the heart (SCOT-HEART) trial: study protocol for randomized controlled trial.

Newby DE, Williams MC, Flapan AD, Forbes JF, Hargreaves AD, Leslie SJ, Lewis SC, McKillop G, McLean S, Reid JH, Sprat JC, Uren NG, van Beek EJ, Boon NA, Clark L, Craig P, Flather MD, McCormack C, Roditi G, Timmis AD, Krishan A, Donaldson G, Fotheringham M, Hall FJ, Neary P, Cram L, Perkins S, Taylor F, Eteiba H, Rae AP, Robb K, Barrie D, Bissett K, Dawson A, Dundas S, Fogarty Y, Ramkumar PG, Houston GJ, Letham D, O'Neill L, Pringle SD, Ritchie V, Sudarshan T, Weir-McCall J, Cormack A, Findlay IN, Hood S, Murphy C, Peat E, Allen B, Baird A, Bertram D, Brian D, Cowan A, Cruden NL, Dweck MR, Flint L, Fyfe S, Keanie C, MacGillivray TJ, Maclachlan DS, MacLeod M, Mirsadraee S, Morrison A, Mills NL, Minns FC, Phillips A, Queripel LJ, Weir NW, Bett F, Divers F, Fairley K, Jacob AJ, Keegan E, White T, Gemmill J, Henry M, McGowan J, Dinnel L, Francis CM, Sandeman D, Yerramasu A, Berry C, Boylan H, Brown A, Duffy K, Frood A, Johnstone J, Lanaghan K, MacDuff R, MacLeod M, McGlynn D, McMillan N, Murdoch L, Noble C, Paterson V, Steedman T, Tzemos N.

Trials. 2012 Oct 4;13:184. doi: 10.1186/1745-6215-13-184.

4.

Brugada-pattern ECG and cardiac arrest in cocaine toxicity: reading between the white lines.

Robertson KE, Martin TN, Rae AP.

Heart. 2010 Apr;96(8):643-4. doi: 10.1136/hrt.2009.183251. No abstract available.

PMID:
20357395
5.

Junctional rhythm--a suitable surrogate endpoint in catheter ablation of atrioventricular nodal reentry tachycardia?

McGavigan AD, Rae AP, Cobbe SM, Rankin AC.

Pacing Clin Electrophysiol. 2005 Oct;28(10):1052-4.

PMID:
16221262
6.

Placebo-controlled evaluations of propafenone for atrial tachyarrhythmias.

Rae AP.

Am J Cardiol. 1998 Oct 16;82(8A):59N-65N. Review.

PMID:
9809902
7.

Coronary artery spasm leading to life threatening arrhythmias.

Adams JN, Denver MA, Rae AP.

Heart. 1998 Jul;80(1):89-90.

8.

Use of fax facility improves decision making regarding thrombolysis in acute myocardial infarction.

Srikanthan VS, Pell AC, Prasad N, Tait GW, Rae AP, Hogg KJ, Dunn FG.

Heart. 1997 Aug;78(2):198-200.

9.

Role of endogenous opioids and catecholamines in vasovagal syncope.

Wallbridge DR, MacIntyre HE, Gray CE, Oldroyd KG, Rae AP, Cobbe SM.

Eur Heart J. 1996 Nov;17(11):1729-36.

PMID:
8922923
10.

Bacterial endocarditis involving a subaortic membrane.

Pentousis D, Cooper JP, Rae AP.

Heart. 1996 Oct;76(4):370-1.

11.

Implantable cardioverter-defibrillators.

Ng GA, Rae AP, Rankin AC, Cobbe SM.

Scott Med J. 1996 Apr;41(2):35-7. No abstract available.

PMID:
8735498
13.

Chemical cardioversion of atrial fibrillation with intravenous dofetilide.

Sedgwick ML, Lip G, Rae AP, Cobbe SM.

Int J Cardiol. 1995 Apr;49(2):159-66.

PMID:
7628887
14.

Pre-dosing antibody levels and efficacy of thrombolytic drugs containing streptokinase.

Gemmill JD, Hogg KJ, Dunn FG, Rae AP, Hillis WS.

Br Heart J. 1994 Sep;72(3):222-5.

15.

Increase in plasma beta endorphins precedes vasodepressor syncope.

Wallbridge DR, MacIntyre HE, Gray CE, Denvir MA, Oldroyd KG, Rae AP, Cobbe SM.

Br Heart J. 1994 Jun;71(6):597-9.

16.

Increase in plasma beta endorphins precedes vasodepressor syncope.

Wallbridge DR, MacIntyre HE, Gray CE, Denvir MA, Oldroyd KG, Rae AP, Cobbe SM.

Br Heart J. 1994 May;71(5):446-8. Corrected and republished in: Br Heart J. 1994 Jun;71(6):597-9.

17.

Failure to reproduce the in vitro cardiac electrophysiological effects of naloxone in humans.

Oldroyd KG, Rankin AC, Gray CE, Harvey K, Borland W, Rae AP, Cobbe SM.

Br J Clin Pharmacol. 1994 Mar;37(3):289-94.

18.
19.

Management of paroxysmal atrial fibrillation.

Lip GY, Metcalfe MJ, Rae AP.

Q J Med. 1993 Aug;86(8):467-72. Review.

PMID:
8210304
21.

Acceleration of ventricular response to atrial flutter after intravenous adenosine.

Rankin AC, Rae AP, Houston A.

Br Heart J. 1993 Mar;69(3):263-5.

22.

Pacing termination of spontaneous ventricular tachycardia in the coronary care unit.

Oldroyd KG, Rankin AC, Rae AP, Cobbe SM.

Int J Cardiol. 1992 Aug;36(2):223-6.

PMID:
1512061
23.
24.

Coronary venous lipid peroxide concentrations after coronary angioplasty: correlation with biochemical and electrocardiographic evidence of myocardial ischaemia.

Oldroyd KG, Paterson JR, Rumley AG, Eteiba H, Rae AP, Shepherd J, Cobbe SM, Hutton I.

Br Heart J. 1992 Jul;68(1):43-7. Erratum in: Br Heart J 1992 Nov;68(5):534.

25.

Early aortic valve cusp rupture in relapsing polychondritis.

Marshall DA, Jackson R, Rae AP, Capell HA.

Ann Rheum Dis. 1992 Mar;51(3):413-5.

26.

A pilot study of the efficacy and safety of bolus administration of alteplase in acute myocardial infarction.

Gemmill JD, Hogg KJ, MacIntyre PD, Booth N, Rae AP, Dunn FG, Hillis WS.

Br Heart J. 1991 Aug;66(2):134-8.

28.

A comparison of the pharmacokinetic properties of streptokinase and anistreplase in acute myocardial infarction.

Gemmill JD, Hogg KJ, Burns JM, Rae AP, Dunn FG, Fears R, Ferres H, Standring R, Greenwood H, Pierce D, et al.

Br J Clin Pharmacol. 1991 Feb;31(2):143-7.

29.

Free radical activity during percutaneous trans-luminal coronary angioplasty.

Paterson JR, Oldroyd KG, Rumley AG, Eteiba H, Rae AP, Hutton I, Cobbe SM.

Biochem Soc Trans. 1990 Dec;18(6):1183-4. No abstract available.

PMID:
2088852
30.

Study of serum C-reactive protein concentration in cardiac failure.

Pye M, Rae AP, Cobbe SM.

Br Heart J. 1990 Apr;63(4):228-30.

31.

Quantification of aortic regurgitation using continuous and pulsed wave Doppler echocardiography.

Pye M, Rae AP, Hutton I, Cobbe SM.

Int J Cardiol. 1990 Apr;27(1):101-6.

PMID:
2335401
32.

Angiographic patency study of anistreplase versus streptokinase in acute myocardial infarction.

Hogg KJ, Gemmill JD, Burns JM, Lifson WK, Rae AP, Dunn FG, Hillis WS.

Lancet. 1990 Feb 3;335(8684):254-8.

PMID:
1967720
33.
34.

Verapamil or adenosine for the immediate treatment of supraventricular tachycardia.

Rankin AC, Rae AP, Oldroyd KG, Cobbe SM.

Q J Med. 1990 Feb;74(274):203-8.

PMID:
2345787
35.

Role of the general practitioner in managing patients with myocardial infarction.

Burns JM, Hogg KJ, Rae AP, Hillis WS, Dunn FG.

BMJ. 1989 Sep 30;299(6703):858. No abstract available.

36.

Value and limitations of adenosine in the diagnosis and treatment of narrow and broad complex tachycardias.

Rankin AC, Oldroyd KG, Chong E, Rae AP, Cobbe SM.

Br Heart J. 1989 Sep;62(3):195-203.

37.

Impact of a policy of direct admission to a coronary care unit on use of thrombolytic treatment.

Burns JM, Hogg KJ, Rae AP, Hillis WS, Dunn FG.

Br Heart J. 1989 Apr;61(4):322-5. Erratum in: Br Heart J 1989 Sep;62(3):240.

38.

Proarrhythmic effects of antiarrhythmic drugs in patients with malignant ventricular arrhythmias evaluated by electrophysiologic testing.

Rae AP, Kay HR, Horowitz LN, Spielman SR, Greenspan AM.

J Am Coll Cardiol. 1988 Jul;12(1):131-9.

39.

Misuse of intravenous verapamil in patients with ventricular tachycardia.

Rankin AC, Rae AP, Cobbe SM.

Lancet. 1987 Aug 29;2(8557):472-4.

PMID:
2887775
40.

Proarrhythmic responses during electrophysiologic testing.

Horowitz LN, Greenspan AM, Rae AP, Kay HR, Spielman SR.

Am J Cardiol. 1987 Apr 30;59(11):45E-48E.

PMID:
3578040
41.

Transpulmonary angiotensin II formation in patients with chronic stable cor pulmonale.

Neilly JB, Clark CJ, Tweddel A, Rae AP, Hughes DM, Hutton I, Morton JJ, Stevenson RD.

Am Rev Respir Dis. 1987 Apr;135(4):891-5.

PMID:
3032031
42.

Electrophysiologic assessment of antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with dilated cardiomyopathy.

Rae AP, Spielman SR, Kutalek SP, Kay HR, Horowitz LN.

Am J Cardiol. 1987 Feb 1;59(4):291-5.

PMID:
3544793
43.

Ultrafiltration in diuretic-resistant cardiac failure.

Simpson IA, Simpson K, Rae AP, Boulton-Jones JM, Allison ME, Hutton I.

Ren Fail. 1987;10(2):115-9.

PMID:
3685478
44.

Proarrhythmic responses during electrophysiologic testing.

Rae AP.

Cardiol Clin. 1986 Aug;4(3):487-96. Review.

PMID:
3530470
45.

Plasma norepinephrine in exercise-induced ventricular tachycardia.

Sokoloff NM, Spielman SR, Greenspan AM, Rae AP, Porter RS, Lowenthal DT, Hakki AH, Iskandrian AS, Kay HR, Horowitz LN.

J Am Coll Cardiol. 1986 Jul;8(1):11-7.

46.

Ultrafiltration in the management of refractory congestive heart failure.

Simpson IA, Rae AP, Simpson K, Gribben J, Boulton Jones JM, Allison ME, Hutton I.

Br Heart J. 1986 Apr;55(4):344-7.

47.

Utility of ambulatory electrocardiographic monitoring for predicting recurrence of sustained ventricular tachyarrhythmias in patients receiving amiodarone.

Sokoloff NM, Spielman SR, Greenspan AM, Rae AP, Brady PM, Kay HR, Horowitz LN.

J Am Coll Cardiol. 1986 Apr;7(4):938-41.

48.

Cardiogenic shock and the haemodynamic effects of arrhythmias.

Rae AP, Hutton I.

Br J Anaesth. 1986 Feb;58(2):151-68. Review. No abstract available.

49.

Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery disease.

Greenspan AM, Spielman SR, Webb CR, Sokoloff NM, Rae AP, Horowitz LN.

Am J Cardiol. 1985 Aug 1;56(4):277-84.

PMID:
4025166
50.

Limitations of failure of procainamide during electrophysiologic testing to predict response to other medical therapy.

Rae AP, Sokoloff NM, Webb CR, Spielman SR, Greenspan AM, Horowitz LN.

J Am Coll Cardiol. 1985 Aug;6(2):410-6.

Supplemental Content

Support Center